Skip to main content
. Author manuscript; available in PMC: 2017 May 4.
Published in final edited form as: Am J Transplant. 2015 Jul 30;15(12):3081–3094. doi: 10.1111/ajt.13399

Table 1.

Treatment groups and skin allograft survival

Treatment Mice per
Group (n)		 Median allograft
Survival (days)
LM gHV PyV
No treatment 5–15 11 12 11
CoB (CTLA4-Ig + anti-CD154) 4–24 12 13 12
Anti-LFA-1 5–15 12 13 12
Anti-VLA-4 5 14 14 11
CoB + anti-LFA-1 5–22 101** 13.5 22*
CoB + anti-VLA-4 5–21 100** 20.5** 14
*

p < 0.01,

**

p < 0.001